PerkinElmer launch to accelerate drug discovery efforts

PerkinElmer, Inc. has launched the EnVision Nexus system, a multimode plate reader to help drive improved research and discovery workflows.

The system is the company’s fastest and most sensitive plate reader to date, and has been designed for high-throughput screening applications. It includes complementary microplates and optimised reagents from Perkin Elmer’s drug discovery reagents portfolio, giving researchers increase assay flexibility.

Alan Fletcher, PerkinElmer senior vice president of life sciences, said: “We’re transforming drug discovery, and it all begins in the lab where researchers can leverage multimode plate reader technology like the EnVision Nexus system to increase R&D productivity at nearly every stage of their process.

“By focusing on workflow simplification and expanded assay capabilities in a state-of-the-art microplate reader, complemented by our optimised reagent technologies, our team has created an all-around high-performing system built for today and the future.”

The PerkinElmer EnVision system has been used in laboratories around the world for over 20 years. The new system features high-throughput and fast dual detectors, which allow researchers to screen millions of samples with increased accuracy, speed and sensitivity.

It works across major detection technologies, including fluorescence intensity, fluorescence polarisation, absorbance, luminescence and time-resolved fluorescence. This allows for a wide-range of assays to be performed for different applications, using just the one instrument.

In addition, the EnVision Nexus can be equipped with a plate-stacker for 20 or 50 plates, or it can be fully automated and integrated for 24/7 workflow-driven automation.